| Schedule of segment reporting information |
| |
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
$ |
324,982 |
|
|
$ |
264,141 |
|
|
$ |
923,205 |
|
|
$ |
795,656 |
|
| Medical related consulting services - related party |
|
|
- |
|
|
|
108,520 |
|
|
|
- |
|
|
|
234,214 |
|
| Development services and sales of developed products |
|
|
- |
|
|
|
10,555 |
|
|
|
- |
|
|
|
37,237 |
|
| Total |
|
|
324,982 |
|
|
|
383,216 |
|
|
|
923,205 |
|
|
|
1,067,107 |
|
| Costs and expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
135,821 |
|
|
|
193,738 |
|
|
|
663,086 |
|
|
|
617,173 |
|
| Medical related consulting services - related party |
|
|
- |
|
|
|
94,442 |
|
|
|
- |
|
|
|
202,908 |
|
| Development services and sales of developed products |
|
|
- |
|
|
|
41,808 |
|
|
|
- |
|
|
|
103,899 |
|
| Total |
|
|
135,821 |
|
|
|
329,988 |
|
|
|
663,086 |
|
|
|
923,980 |
|
| Gross profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
189,161 |
|
|
|
70,403 |
|
|
|
260,119 |
|
|
|
178,483 |
|
| Medical related consulting services - related party |
|
|
- |
|
|
|
14,078 |
|
|
|
- |
|
|
|
31,306 |
|
| Development services and sales of developed products |
|
|
- |
|
|
|
(31,253 |
) |
|
|
- |
|
|
|
(66,662 |
) |
| Total |
|
|
189,161 |
|
|
|
53,228 |
|
|
|
260,119 |
|
|
|
143,127 |
|
| Other operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
77,852 |
|
|
|
75,750 |
|
|
|
291,886 |
|
|
|
253,347 |
|
| Medical related consulting services - related party |
|
|
160,557 |
|
|
|
206,085 |
|
|
|
491,683 |
|
|
|
446,156 |
|
| Development services and sales of developed products |
|
|
28,002 |
|
|
|
1,132,015 |
|
|
|
94,241 |
|
|
|
1,574,973 |
|
| Corporate/Other |
|
|
3,113,308 |
|
|
|
4,115,725 |
|
|
|
8,797,886 |
|
|
|
12,154,063 |
|
| Total |
|
|
3,379,719 |
|
|
|
5,529,575 |
|
|
|
9,675,696 |
|
|
|
14,428,539 |
|
| Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(32,877 |
) |
| Corporate/Other |
|
|
(41,531 |
) |
|
|
(11,198 |
) |
|
|
(126,169 |
) |
|
|
(27,423 |
) |
| Total |
|
|
(41,531 |
) |
|
|
(11,198 |
) |
|
|
(126,169 |
) |
|
|
(60,300 |
) |
| Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
4 |
|
|
|
2,157 |
|
|
|
(927 |
) |
|
|
2,172 |
|
| Medical related consulting services - related party |
|
|
(20,095 |
) |
|
|
(8,825 |
) |
|
|
(36,673 |
) |
|
|
(30,679 |
) |
| Development services and sales of developed products |
|
|
221 |
|
|
|
18 |
|
|
|
224 |
|
|
|
197 |
|
| Corporate/Other |
|
|
- |
|
|
|
1,160,137 |
|
|
|
- |
|
|
|
1,096,212 |
|
| Total |
|
|
(19,870 |
) |
|
|
1,153,487 |
|
|
|
(37,376 |
) |
|
|
1,067,902 |
|
| Total other income (expense) |
|
|
(61,401 |
) |
|
|
1,142,289 |
|
|
|
(163,545 |
) |
|
|
1,007,602 |
|
| Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operations |
|
|
111,313 |
|
|
|
(3,190 |
) |
|
|
(32,694 |
) |
|
|
(105,569 |
) |
| Medical related consulting services - related party |
|
|
(180,652 |
) |
|
|
(200,832 |
) |
|
|
(528,356 |
) |
|
|
(445,529 |
) |
| Development services and sales of developed products |
|
|
(27,781 |
) |
|
|
(1,163,250 |
) |
|
|
(94,017 |
) |
|
|
(1,641,438 |
) |
| Corporate/Other |
|
|
(3,154,839 |
) |
|
|
(2,966,786 |
) |
|
|
(8,924,055 |
) |
|
|
(11,085,274 |
) |
| Total |
|
$ |
(3,251,959 |
) |
|
$ |
(4,334,058 |
) |
|
$ |
(9,579,122 |
) |
|
$ |
(13,277,810 |
) |
|